The 2018 PDA Cell and Gene Therapy Conference will provide a broad overview of current innovations with a focus on what it takes to successfully steward these therapies toward approval and beyond. Hear presentations from a lineup of distinguished industry and regulatory speakers including Dr. Peter Marks, MD, PhD, Director, CBER, U.S FDA, who will present the Regulatory Perspective on Considerations for Development and Commercialization of Cell and Gene Therapies.
Back to All Events
Earlier Event: October 222nd Annual Gene Therapies for Rare Disorders Meeting Europe
Later Event: October 23ASTM E55 October 2018 Meeting